Elixxer Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Public

  • Stock Symbol
  • ELXR.H

Stock Symbol

  • Investments
  • 9

  • Share Price
  • $0.01
  • (As of Friday Closing)

Elixxer General Information

Description

Elixxer Ltd is a Canada-based cannabis investment firm in the legal cannabis market. It invests in cannabis-related businesses that are fully licensed for the cultivation, production, and sale of cannabis and cannabis-derived products.

Contact Information

Website
www.elixxer.com
Formerly Known As
LGC Capital Ltd, Buzz Telecommunications Services
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 800 Place Victoria
  • Suite 3700
  • Montreal, Quebec H4Z 1E9
  • Canada
+1 (514)
Primary Industry
Other Financial Services
Stock Exchange
TSX
Corporate Office
  • 800 Place Victoria
  • Suite 3700
  • Montreal, Quebec H4Z 1E9
  • Canada
+1 (514)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Elixxer Stock Performance

As of 13-Nov-2026, Elixxer’s stock price is $0.01. Its current market cap is $1.34M with 95.3M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.01 $0.03 $0.01 - $0.06 $1.34M 95.3M 3.42K -$0.18

Elixxer Financials Summary

As of 30-Jun-2026, Elixxer has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 9,272 10,295
Revenue 0 0 0 0
EBITDA (1,195) (910) (1,038)
Net Income (2,449) (2,771) (2,528) (2,968)
Total Assets 718 777 1,487 2,116
Total Debt 7,414 7,212 8,301 7,280
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Elixxer Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Elixxer‘s full profile, request access.

Request a free trial

Elixxer Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Elixxer‘s full profile, request access.

Request a free trial

Elixxer Investments & Acquisitions (9)

Elixxer’s most recent deal was a Secondary Transaction - Private with Little Green Pharma. The deal was made on 26-Aug-2019.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Little Green Pharma 26-Aug-2019 Secondary Transaction - Private Other Pharmaceuticals and Biotechnology
Freia Farmaceutici 29-Jul-2019 Later Stage VC Drug Discovery
Viridi Unit 12-Dec-2018 Corporate Cultivation
EasyJoint 12-Nov-2018 Corporate Pharmaceuticals
CLV Frontier Brands 11-Jan-2018 Joint Venture Beverages
You’re viewing 5 of 9 investments and acquisitions. Get the full list »

Elixxer ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Diversified Financials

Industry

Rank

Percentile

Asset Management and Custody Services

Subindustry

Rank

Percentile

To view Elixxer’s complete esg history, request access »

Elixxer Exits (1)

Elixxer’s most recent exit was on 12-Dec-2018 from Viridi Unit. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Viridi Unit 12-Dec-2018 Completed
To view Elixxer’s complete exits history, request access »

Elixxer FAQs

  • When was Elixxer founded?

    Elixxer was founded in 2004.

  • Where is Elixxer headquartered?

    Elixxer is headquartered in Montreal, Canada.

  • What industry is Elixxer in?

    Elixxer’s primary industry is Other Financial Services.

  • Is Elixxer a private or public company?

    Elixxer is a Public company.

  • What is Elixxer’s stock symbol?

    The ticker symbol for Elixxer is ELXR.H.

  • What is the current stock price of Elixxer?

    As of 13-Nov-2026 the stock price of Elixxer is $0.01.

  • What is the current market cap of Elixxer?

    The current market capitalization of Elixxer is $1.34M.

  • What is Elixxer’s annual earnings per share (EPS)?

    Elixxer’s EPS for 12 months was -$0.18.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process